Customer-Talks-Part-1-MEDDIC

Customer Talks Part 1: How iSEEit supported the roll out of MEDDIC on Salesforce

/162 Comments/in , /by

Have you always wondered how the MEDDIC sales process can be implemented on Salesforce? In part 1 of this special 2-part customer talks series, we sat down with some sales leaders to find out how iSEEit aided them in the seamless implementation of the MEDDIC sales process. Watch the video below to find out more! A full transcript of this interview is also available.

 


iSEEit: How did iSEEit support the roll out of MEDDIC?

Rob Desmond, Quinyx (RB): With the iSEEit platform, we can very quickly get a glimpse into what gaps we have in the sales process, why we’ve identified specific folks as coaches, champions or influencers. With the org chart and the scorecard, we get a quick glimpse from a forecast perspective on where we should be focusing our time, coming full circle back to how we kicked this off.

Ian Gilbert, Guidespark (IG): As a leader, you often are forcing the dialogue on MEDDIC, and you can do that in the most respectful and collaborative way as you want, but you’re still forcing it and the act of turning MEDDIC into a tool that sales professionals own, use and rely on, is a journey and takes some time. That’s way less true as you embed iSEEit into your salesforce implementation.

Blake Tablak, Workiva (BT): It’s really important that we establish an operating cadence. Salesforce is our system of records, so it makes sense to embed this (iSEEit opportunity management system) into Salesforce.

IG: (iSEEit) begins to put it right into the flow of work for sales people because those are things that you’re still going to do – the qualification review and deal inspection sessions, the training and enablement sessions – they become augmentation to a language or a series of steps that sales people are using naturally moment by moment.

 

Watch part 2 here!

Curious to find out more about implementing MEDDIC on Salesforce? Click the link below to learn more!

LEARN MORE

 

162 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *